← Evidence map

ArticleOncogene2025

Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.

Nobutoshi Esaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41120731